307 related articles for article (PubMed ID: 26655549)
1. Mitral regurgitation prior to transcatheter aortic valve implantation influences survival but not symptoms.
Boerlage-van Dijk K; Wiegerinck EM; Takama T; Koch KT; Vis MM; de Mol BA; Piek JJ; Bouma BJ; Baan J
Int J Cardiol; 2016 Feb; 204():95-100. PubMed ID: 26655549
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter aortic valve implantation reduces grade of concomitant mitral and tricuspid valve regurgitation and pulmonary hypertension.
Wilbring M; Tugtekin SM; Ritzmann M; Arzt S; Schmidt T; Matschke K; Kappert U; Alexiou K
Eur J Cardiothorac Surg; 2014 Nov; 46(5):818-24. PubMed ID: 24574441
[TBL] [Abstract][Full Text] [Related]
3. Tricuspid but not Mitral Regurgitation Determines Mortality After TAVI in Patients With Nonsevere Mitral Regurgitation.
Amat-Santos IJ; Castrodeza J; Nombela-Franco L; Muñoz-García AJ; Gutiérrez-Ibanes E; de la Torre Hernández JM; Córdoba-Soriano JG; Jiménez-Quevedo P; Hernández-García JM; González-Mansilla A; Ruano J; Tobar J; Del Trigo M; Vera S; Puri R; Hernández-Luis C; Carrasco-Moraleja M; Gómez I; Rodés-Cabau J; San Román JA
Rev Esp Cardiol (Engl Ed); 2018 May; 71(5):357-364. PubMed ID: 29079280
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter aortic valve implantation in patients with concomitant mitral and tricuspid regurgitation.
Hutter A; Bleiziffer S; Richter V; Opitz A; Hettich I; Mazzitelli D; Ruge H; Lange R
Ann Thorac Surg; 2013 Jan; 95(1):77-84. PubMed ID: 23063197
[TBL] [Abstract][Full Text] [Related]
5. The beneficial effects of TAVI in mitral insufficiency.
Costantino MF; Dores E; Innelli P; Matera A; Santillo V; Violini R; Fiorilli R; Cappabianca G; Marraudino N; Picano E; Tarsia G
Cardiovasc Ultrasound; 2015 Dec; 13():49. PubMed ID: 26714887
[TBL] [Abstract][Full Text] [Related]
6. Mitral valve regurgitation in patients undergoing TAVI: Impact of severity and etiology on clinical outcome.
Muratori M; Fusini L; Tamborini G; Ghulam Ali S; Gripari P; Fabbiocchi F; Salvi L; Trabattoni P; Roberto M; Agrifoglio M; Alamanni F; Bartorelli AL; Pepi M
Int J Cardiol; 2020 Jan; 299():228-234. PubMed ID: 31353154
[TBL] [Abstract][Full Text] [Related]
7. Does the Presence of Significant Mitral Regurgitation prior to Transcatheter Aortic Valve Implantation for Aortic Stenosis Impact Mortality? - Meta-Analysis and Systematic Review.
Sethi A; Kodumuri V; Prasad V; Chaudhary A; Coromilas J; Kassotis J
Cardiology; 2020; 145(7):428-438. PubMed ID: 32460301
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact and change of concomitant mitral regurgitation after surgical or transcatheter aortic valve replacement for aortic stenosis.
Fojt R; Moťovská Z; Budera P; Malý M; Straka Z
J Cardiol; 2016 Jun; 67(6):526-30. PubMed ID: 26972342
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of mortality outcomes and mitral regurgitation evolution in 4,839 patients having transcatheter aortic valve implantation for severe aortic stenosis.
Sannino A; Losi MA; Schiattarella GG; Gargiulo G; Perrino C; Stabile E; Toscano E; Giugliano G; Brevetti L; Franzone A; Cirillo P; Imbriaco M; Trimarco B; Esposito G
Am J Cardiol; 2014 Sep; 114(6):875-82. PubMed ID: 25092192
[TBL] [Abstract][Full Text] [Related]
10. Does residual aortic regurgitation after transcatheter aortic valve implantation increase mortality in all patients? The importance of baseline natriuretic peptides.
Borz B; Durand E; Godin M; Tron C; Canville A; Hauville C; Bauer F; Cribier A; Eltchaninoff H
Int J Cardiol; 2014 May; 173(3):436-40. PubMed ID: 24679693
[TBL] [Abstract][Full Text] [Related]
11. Impact of mitral regurgitation on clinical outcomes of patients with low-ejection fraction, low-gradient severe aortic stenosis undergoing transcatheter aortic valve implantation.
O'Sullivan CJ; Stortecky S; Bütikofer A; Heg D; Zanchin T; Huber C; Pilgrim T; Praz F; Buellesfeld L; Khattab AA; Blöchlinger S; Carrel T; Meier B; Zbinden S; Wenaweser P; Windecker S
Circ Cardiovasc Interv; 2015 Feb; 8(2):e001895. PubMed ID: 25657315
[TBL] [Abstract][Full Text] [Related]
12. Mitral and aortic regurgitation following transcatheter aortic valve replacement.
Szymański P; Hryniewiecki T; Dąbrowski M; Sorysz D; Kochman J; Jastrzębski J; Kukulski T; Zembala M
Heart; 2016 May; 102(9):701-6. PubMed ID: 26908096
[TBL] [Abstract][Full Text] [Related]
13. Natural history of coexistent mitral regurgitation after aortic valve replacement.
Schubert SA; Yarboro LT; Madala S; Ayunipudi K; Kron IL; Kern JA; Ailawadi G; Stukenborg GJ; Ghanta RK
J Thorac Cardiovasc Surg; 2016 Apr; 151(4):1032-9, 1042.e1. PubMed ID: 26876419
[TBL] [Abstract][Full Text] [Related]
14. Impact of Functional Versus Organic Baseline Mitral Regurgitation on Short- and Long-Term Outcomes After Transcatheter Aortic Valve Replacement.
Kiramijyan S; Koifman E; Asch FM; Magalhaes MA; Didier R; Escarcega RO; Negi SI; Baker NC; Jerusalem ZD; Gai J; Torguson R; Okubagzi P; Wang Z; Shults CC; Ben-Dor I; Corso PJ; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2016 Mar; 117(5):839-46. PubMed ID: 26873331
[TBL] [Abstract][Full Text] [Related]
15. Relationship between Mitral Regurgitation and Transcatheter Aortic Valve Implantation: a Multi-Institutional Follow-up Study.
Cunha LCBPD; Guerios EE; Cunha CLPD; Carvalho LA; Lemos Neto P; Sarmento-Leite R; Abizaid AA; Mangione JA; Oliveira AD; Siciliano A; Esteves V; Brito FS
Arq Bras Cardiol; 2021 Jun; 116(6):1059-1069. PubMed ID: 34133587
[TBL] [Abstract][Full Text] [Related]
16. The impact of functional vs degenerative mitral regurgitation on clinical outcomes among patients undergoing transcatheter aortic valve implantation.
Vollenbroich R; Stortecky S; Praz F; Lanz J; Franzone A; Zuk K; Heg D; Valgimigli M; O'Sullivan CJ; Heinisch C; Roost E; Wenaweser P; Windecker S; Pilgrim T
Am Heart J; 2017 Feb; 184():71-80. PubMed ID: 27892889
[TBL] [Abstract][Full Text] [Related]
17. Analysis of long-term survival following transcatheter aortic valve implantation from a single high-volume center.
Escárcega RO; Lipinski MJ; Baker NC; Magalhaes MA; Minha S; Torguson R; Chen F; Ben-Dor I; Satler LF; Pichard AD; Corso P; Waksman R
Am J Cardiol; 2015 Jul; 116(2):256-63. PubMed ID: 25978977
[TBL] [Abstract][Full Text] [Related]
18. Interplay between mitral regurgitation and transcatheter aortic valve replacement with the CoreValve Revalving System: a multicenter registry.
Bedogni F; Latib A; De Marco F; Agnifili M; Oreglia J; Pizzocri S; Latini RA; Lanotte S; Petronio AS; De Carlo M; Ettori F; Fiorina C; Poli A; Cirri S; De Servi S; Ramondo A; Tarantini G; Marzocchi A; Fiorilli R; Klugmann S; Ussia GP; Tamburino C; Maisano F; Brambilla N; Colombo A; Testa L
Circulation; 2013 Nov; 128(19):2145-53. PubMed ID: 24088530
[TBL] [Abstract][Full Text] [Related]
19. Impact of preprocedural mitral regurgitation upon mortality after transcatheter aortic valve implantation (TAVI) for severe aortic stenosis.
Khawaja MZ; Williams R; Hung J; Arri S; Asrress KN; Bolter K; Wilson K; Young CP; Bapat V; Hancock J; Thomas M; Redwood S
Heart; 2014 Nov; 100(22):1799-803. PubMed ID: 25155800
[TBL] [Abstract][Full Text] [Related]
20. Change in mitral regurgitation severity impacts survival after transcatheter aortic valve replacement.
Feldt K; De Palma R; Bjursten H; Petursson P; Nielsen NE; Kellerth T; Jönsson A; Nilsson J; Rück A; Settergren M
Int J Cardiol; 2019 Nov; 294():32-36. PubMed ID: 31399298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
